ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript - Thomson StreetEvents

ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript

ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript - Thomson StreetEvents
ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript
Published Nov 04, 2020
Published Nov 04, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ACAD.OQ earnings conference call or presentation 4-Nov-20 9:30pm GMT

  
Report Type:

Transcript

Source:
Company:
ACADIA Pharmaceuticals Inc
Ticker
ACAD.OQ
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gregory James Renza - RBC Capital Markets, Research Division - Analyst : Congrats on the quarter. Steve, just wanted to focus on Europe for a moment. And perhaps you could just provide your latest or refreshed views on the plan to unlock value with pimavanserin now that we're getting closer to 2021 and a potential DRP approval here stateside. And perhaps REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. NOVEMBER 04, 2020 / 9:30PM, ACAD.OQ - Q3 2020 ACADIA Pharmaceuticals Inc Earnings Call just analogously, just thinking about the schizophrenia trial that launched this quarter, just curious if you had any thoughts about how that is progressing, given that it's in Europe and the foresight of any potential impact with cases of COVID-19 there?


Question: Sumant Satchidanand Kulkarni - Canaccord Genuity Corp., Research Division - Analyst : So from a commercial perspective, if a disease-modifying product is approved for Alzheimer's disease and is on the market, do you foresee any competitive impact at all for allocation of the payers' reimbursement dollar pipe for symptom management products such as pimavanserin when you hit the market next year for DRP?

Table Of Contents

ACADIA Pharmaceuticals Inc Q4 2020 Earnings Call Summary – 2021-02-24 – US$ 54.00 – Edited Brief of ACAD.OQ earnings conference call or presentation 24-Feb-21 9:30pm GMT

ACADIA Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-24 – US$ 54.00 – Edited Transcript of ACAD.OQ earnings conference call or presentation 24-Feb-21 9:30pm GMT

ACADIA Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-12 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 12-Jan-21 7:00pm GMT

ACADIA Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript – 2020-11-17 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 17-Nov-20 8:20pm GMT

ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Summary – 2020-11-04 – US$ 54.00 – Edited Brief of ACAD.OQ earnings conference call or presentation 4-Nov-20 9:30pm GMT

ACADIA Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript – 2020-09-16 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 16-Sep-20 3:20pm GMT

ACADIA Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-14 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 14-Sep-20 7:45pm GMT

ACADIA Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) - Panel: Emerging Therapies for Psychiatric Disorders Transcript – 2020-09-09 – US$ 54.00 – Edited Transcript of ACAD.OQ presentation 9-Sep-20 5:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript" Nov 04, 2020. Alacra Store. May 13, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2020-ACADIA-Pharmaceuticals-Inc-Earnings-Call-T13456042>
  
APA:
Thomson StreetEvents. (2020). ACADIA Pharmaceuticals Inc Q3 2020 Earnings Call Transcript Nov 04, 2020. New York, NY: Alacra Store. Retrieved May 13, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2020-ACADIA-Pharmaceuticals-Inc-Earnings-Call-T13456042>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.